Why Evidence Generation Should Matter to Payers-Reply
JAMA
.
2024 Nov 14.
doi: 10.1001/jama.2024.20647.
Online ahead of print.
Authors
Ali B Abbasi
1
,
Lesley H Curtis
1
,
Robert M Califf
1
Affiliation
1
US Food and Drug Administration, Silver Spring, Maryland.
PMID:
39541101
DOI:
10.1001/jama.2024.20647
No abstract available